SeqOne to acquire Congenica.

SeqOne, a European provider of AI-powered software for next-generation sequencing data analysis in oncology and rare diseases, agreed to acquire Congenica, a digital health company providing software and solutions for the analysis and interpretation of genomic data at scale. Financial terms were not disclosed. The acquisition unites SeqOne’s AI-powered platform for Next-Generation Sequencing analysis with Congenica’s trusted clinical decision support technology and clinical interpretation services. The integrated offering will transform complex genomic data into rapid, actionable insights, ultimately accelerating diagnosis for families affected by rare disease and enabling more precise, personalized cancer therapies.